Table 1 General characteristics of 376 patients with undetectable HIV-RNA switching to dual therapy
N (%) | Median (IQ range) | |
|---|---|---|
Male gender | 286 (76.1) | |
Age | 50 (45–55) | |
Non-Italian origin | 38 (10.1) | |
Years on cART | 13 (7–16) | |
IDU as risk factor | 98 (26.1) | |
AIDS diagnosis | 127 (33.8) | |
N. of prev. regimens | 5 (3–9) | |
CD4+ nadir | 123 (46–243) | |
Baseline CD4+ count | 534 (341–701) | |
HCV co-infection | 123 (32.7) | |
Prev. GRT for VF | 238 (63.3) | |
Switch to PI/r | ||
ATV/r | 69 (18.4) | |
DRV/r | 237 (63.0) | |
LPV/r | 70 (18.6) | |
Switch to second drug | ||
ETR | 62 (16.5) | |
RAL | 202 (53.7) | |
MVC | 65 (17.3) | |
3TC | 23 (6.1) | |
TDF | 24 (6.4) | |